|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/13 | (2006.01) |
| A61P 25/00 | (2006.01) |
| (11) | Number of the document | 3416631 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17767934.7 |
| Date of filing the European patent application | 2017-08-11 | |
| (97) | Date of publication of the European application | 2018-12-26 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-15 |
| (46) | Date of publication of the claims translation | 2019-08-26 |
| (86) | Number | PCT/IB2017/054929 |
| Date | 2017-08-11 |
| (87) | Number | WO 2018/029658 |
| Date | 2018-02-15 |
| (30) | Number | Date | Country code |
| 201613829 | 2016-08-11 | GB | |
| 201702551 | 2017-02-16 | GB | |
| 201705766 | 2017-04-10 | GB | |
| 201706867 | 2017-04-28 | GB |
| (72) |
STRUPP, Michael, DE
|
| (73) |
Intrabio Ltd,
Begbroke Science Park Begbroke Hill Woodstock Road, Begbroke, Oxfordshire OX5 1PF,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Terapiniai agentai, skirti neurodegeneracinių ligų gydymui |
| THERAPEUTIC AGENTS FOR NEURODEGENERATIVE DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-06-19 | 9 | 208.00 EUR |
| 2026-08-11 |